American Tower Prices €1 Billion Senior Notes Offering

American Tower Corporation (NYSE: AMT) has announced the pricing of its registered public offering of senior unsecured notes due 2030 and 2034 in aggregate principal amounts of €500.0 million (approximately $543.5 million) each. The 2030 notes will carry an interest rate of 3.900% per annum and are being issued at a price equal to 99.622% of their face value. On the other hand, the 2034 notes will have an interest rate of 4.100% per annum and are being issued at a price equal to 99.306% of their face value.

The net proceeds of the offering are expected to be approximately €988.4 million (approximately $1,074.2 million), after deducting underwriting discounts and estimated offering expenses. These proceeds are intended to be used by American Tower to repay existing indebtedness under its $6.0 billion senior unsecured multicurrency revolving credit facility, as well as to repay existing indebtedness under its €825.0 million unsecured term loan.

Banco Santander, S.A., Barclays Bank PLC, Citigroup Global Markets Limited, J.P. Morgan Securities PLC, and Mizuho International PLC are acting as joint book-running managers for the offering.

This announcement comes as American Tower, one of the largest global REITs, continues to solidify its position as a leading independent owner, operator, and developer of multitenant communications real estate, boasting a portfolio of over 224,000 communications sites and a highly interconnected footprint of U.S. data center facilities. As a result of these announcements, the company's shares have moved -0.9% on the market, and are now trading at a price of $189.69. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.